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Emergence of resistance against multiple types or classes of antibiotics among bacterial 
pathogens associated with Acute Respiratory Infection (ARI) is a global concern. Since, ARI still 
remains the major cause of child death worldwide, this loss of effectiveness of antibiotics can 
cause severe health problems of children suffering from acute respiratory infections. Acute 
respiratory infection (ARI) is the leading cause of mortality and morbidity among <5 children in 
developing countries like Bangladesh. In this study we focused on elucidating the correlation 
between antibiotic resistance and plasmids in two multi-drug resistant bacterial respiratory 
isolates obtained from an ARI surveillance study conducted in Dhaka. From 196 nasal swab 
specimens collected for a systematic ARI surveillance study from under-five patients presented 
to Dhaka Medical College Hospital (DMCH) and Shaheed Suhrawardy Medical College 
Hospital (SSMCH), Two isolates of multidrug resistant (MDR) bacteria-one Klebsiella 
pneumoniae and Enterobacter aggalomerans were found. The isolates were identified and 
confirmed by microbiological culture and appropriate biochemical tests, and their multi-drug 
resistance characteristics were confirmed by disc diffusion method. Plasmid curing was 
performed on the two MDR isolates using Ethidium bromide, SDS, and elevated temperature 
curing methods, and antibiotic sensitivity testing was performed to check its effect on their 
multi-drug resistance. Both isolates were found resistant towards ampicillin, azithromycin, 
levofloxacin, amoxicillin, tobramycin, cefixime, cefotaxime, penicillin, gentamycin, imipenem, 
trimethoprim and gentamycin. The minimum inhibitory concentration (MICs) of Ethidium 
bromide was determined. Loss of plasmid by Ethidium bromide treatment correlated with loss of 
resistance to antibiotics in cured strains. Plasmid curing with SDS produced similar results. 
Curing plasmid DNA by elevated temperature (45°C) produced significant changes in 
Enterobacter aggalomerans cells but had little effect on K. pneumoniae. The results of this study 
can help direct the mechanistic investigation of multi-drug resistance in respiratory pathogens 





CHAPTER 1: INTRODUCTION 
1.1 Background of the study 
Acute respiratory tract infections are among the most common illnesses all around the world. It 
is a severe infection that precludes normal breathing function. It usually arises as a viral infection 
in the nose, trachea (windpipe), or lungs. If the infection is not cured, it can spread to the entire 
respiratory system. Severity of Acute respiratory infection may result in death. Correspondingly, 
acute respiratory infections are transmissible, which means they can spread from one person to 
another. 
Children are particularly susceptible to acute respiratory infections (ARI). According to the 
World Health Organization, ARI kill an estimated 2.6 million children annually worldwide 
(WHO, 1986). 
ARI contributes to 2-4% of all deaths in children <5 years of age in developed countries, and 
19% to 21% in the Eastern Mediterranean, Africa, and South East Asia regions (Emmelin, 2007). 
ARI causes 10%-15% of all infant deaths in developed countries. This figure rises to 27% in the 
developing world. The total number of acute respiratory infection episodes in <5 children has 
been estimated to range between 500 and 900 million a year in developing countries. In the 
absence of appropriate treatment, 15-25% of all children with pneumonia would die (UNICEF, 
1992). 
Acute respiratory infection is considered as one of the commonest cause of death and sickness 
among <5 children in developing countries including Bangladesh. A joint WHO and UNICEF 
statement says that acute respiratory infections, diarrheal diseases and malnutrition are the major 
reasons of illness and death in children in the developing countries (WHO, 1986). 
Health information unit of national health services of Bangladesh show that the frequency of 
ARI among all outpatients in a rural health complex was 18.2%, of which 16% were children 
between 0-5 years of age (Akbar, 1986). 
According to a statistical report the total morbidity percentage due to ARI was 8.8% (Bangladesh 
Health Services Report , 1990). 
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According to the 2011 report of Bangladesh Demographic and Health Survey (BDHS) the 
morbidity percentage of children under-five with symptoms of ARI is about 6% (Associates, 
2011). In recent, emerging threats of ARI causing multidrug resistant gram negative bacteria are 
mounting the mortality and morbidity rate of child < 5.  ARIs causing bacteria that are inherently 
resistant or that can acquire resistance are surviving and replacing the drug-susceptible bacteria. 
This is really a matter of concern that the number of < 5 aged children is infected by the 
multidrug resistant ARI causing microorganisms.  
The study under question here is an extension of the work on acute respiratory and enteric 
infection of under-five children in Dhaka already going on at Institute for Developing Science 
and Health Initiatives (ideSHi). Two multidrug resistant ARI causing gram negative isolates, 
namely Klebsiella pneumoniae and Enterobacter aggalomerans were found which are resistant 
against 11 and more antibiotics. 
1.2 Acute respiratory infections (ARIs) 
Acute respiratory infections (ARIs) are classified as upper respiratory tract infections (URIs) or 
lower respiratory tract infections (LRIs). 
1.2.1 Upper Respiratory Tract Infections 
Upper Respiratory Tract Infections  include rhinitis (common cold), sinusitis, ear infections, 
acute pharyngitis or tonsillopharyngitis, epiglottitis, and laryngitis—of which ear infections and 
pharyngitis cause more severe complications including  deafness and acute rheumatic fever; 
respectively. The vast majority of URI’s have viral etiology. Rhinoviruses account for 25 to 30 
percent of URIs; respiratory syncytial viruses (RSVs), Para influenza and influenza viruses, 
human metapneumovirus, and adenoviruses for 25 to 35 percent; corona viruses for 10 percent; 
and unidentified viruses for the remainder (Denny, 1995). Because most URIs is self-limiting, 
their complications are more important than the infections. Acute viral infections predispose 
children to bacterial infections of the sinuses and middle ear (Berman, 1995), and aspiration of 
infected secretions and cells can result in LRIs. 
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1.2.1.1 Pathogenesis: Pathogenesis occurs by inhalation of droplets after which organisms gain 
entry to the respiratory tract and invade the mucosa. Epithelial destruction may result, along with 
redness, edema, hemorrhage and sometimes an exudate. 
1.2.1.2 Clinical Manifestations: 
Acute upper respiratory tract infections include rhinitis, pharyngitis/tonsillitis and laryngitis, 
often referred to as a common cold, and their complications: sinusitis, ear infection and 
sometimes bronchitis (though bronchi are classified as part of the lower respiratory 
tract).Symptoms of URTIs commonly include cough, sore throat, runny nose, nasal congestion, 
headache, low grade fever, facial pressure and sneezing. Onset of symptoms usually begins 1–3 
days after exposure. The illness usually lasts 7–10 days. 
Group A beta hemolytic streptococcal pharyngitis/tonsillitis (strep throat) typically presents with 
a sudden onset of sore throat, pain with swallowing and fever. Strep throat does not usually cause 
runny nose, voice changes, or cough. 
1.2.2 Lower respiratory tract infections 
Pneumonia and bronchiolitis are the common lower respiratory tract infections (LRIs) in 
children. The respiratory rate is considered as main clinical sign for diagnosing acute LRIs in 
children who are coughing and breathing promptly. The presence of lower chest wall indrawing 
identifies more severe disease (Mulholland et al.1992; Shann et al., 1984). 
1.2.2.1 Pathogenesis: Organisms enter the distal airway by inhalation or aspiration. The 
pathogen multiplies in or on the epithelium, causing inflammation, increased mucus secretion, 
and impaired mucociliary function; other lung functions may also be affected. In severe 
bronchiolitis, inflammation and necrosis of the epithelium may block small airways leading to 
airway obstruction. 
1.2.2.2 Clinical Manifestations: 
Lower respiratory tract infection (LRTI), while often used as a synonym for pneumonia, can also 
be applied to other types of infection including lung abscess and acute bronchitis. Symptoms 
include shortness of breath, weakness, fever, coughing and fatigue. 
 
5 
There are a number of infections that can affect the lower respiratory tract. As it mentioned 
earlier, the two most common are bronchitis and pneumonia (Therapeutic Guidelines; 2006), but 
Influenza can affects both the upper and lower respiratory tracts. 
As of 2010, lower respiratory infections cause about 2.8 million deaths down from 3.4 million in 
1990 (Therapeutic guidelines, 2000). 
In 2013, LRTIs caused about 2.7 million deaths, whereas in the year of 1990 about 3.4 million 
deaths occurred .This was 4.8% of all deaths in 2013 (Disease Study 2013). 
 
                          Figure 1.1: Upper and lower respiratory tract of human body. 
1.3 Understanding gram negative and gram positive bacteria 
According to the Gram staining theory, bacteria can be differentiated by the chemical and 
physical properties of bacterial cell walls by detecting the presence of peptidoglycan layer. 
Gram-positive bacteria take up the crystal violet stain used in the Gram staining, and then appear 
purple-colored when seen through a microscope. Gram positive bacteria consisting of thick 
peptidoglycan layer in the bacterial cell wall retain the stain after it is washed away from the rest 




Figure 1.2: The image on the left shows Gram-positive bacteria, which retain a purple 
stain. The image on the right is Gram-negative bacteria, which appear pink or red. (Image 
courtesy: CDC). 
Gram-negative bacteria cannot retain the violet stain after the decolorization step; alcohol used in 
this stage degrades the outer membrane of gram-negative cells making the cell wall more porous 
and incapable of retaining the crystal violet stain. Their peptidoglycan layer is much thinner and 
sandwiched between an inner cell membrane and a bacterial outer membrane, causing them to 
take up the counter stain (safranin or fuchsine) and appear red or pink. 
Both structurally and chemically, Gram negative cell walls are more complex than gram positive 
cell walls. 
1.4 Etiology of ARI’s 
The causative agents of ARIs include a wide variety of microorganisms such as Streptococcus 
pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis (Bartlett, 1995). Streptococcus 
pneumoniae (gram positive), usually called pneumococcus and some of gram negative bacteria 
especially Klebsiella pneumoniae and Haemophilus influenza are the most common cause of 
bacterial pneumonia worldwide. Klebsiella pneumoniae responsible for about 30 percent of the 
total pneumonia case load with at least half of the cases occurring in the developing world. The 
Infectious Diseases Society of America (IDSA) has identified six pathogens as particular threats 
of multidrug resistance. Klebsiella pneumoniae is one of them, (Boucher et al., 2004).  
Haemophilus influenza type b (Hib) is involved in as many as 20 percent of the world’s severe 
pneumonia cases. These bacteria, which also cause meningitis and other severe infections, were 
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responsible for 7.9 million cases of pneumonia in 2000, resulting in the deaths of an estimated 
300,000 children age under five. 
Infants can obtain lung infections before birth by breathing infected amniotic fluid or through a 
blood-borne infection through the placenta. Infants can also inhale contaminated fluid from the 
vagina at birth. The most prevalent pathogen causing ARIs in newborns is Streptococcus 
agalactiae, also known as group-B streptococcus (GBS). GBS causes more than half of ARIs in 
the first week after birth (Webber et al., 1990). Other bacterial causes of neonatal infection 
include Listeria monocytogenes and a variety of mycobacteria. Another group is Chlamydia 
trachomatis, acquired at birth but not causing pneumonia until two to four weeks later. 
 
Figure 1.3:  Bacterial pathogens responsible for pneumonia (ARI). (Ref: World lung 
foundation) 
In older infants, infection can occur due to exposure to microorganisms, with common bacterial 
causes including Streptococcus pneumoniae, Escherichia coli, Klebsiella pneumoniae, 
Moraxella catarrhalis and Staphylococcus aureus. While children older than one month tend to 
be at risk for the same microorganisms as adults, children under five are much less likely to have 
pneumonia caused by Mycoplasma pneumoniae, Chlamydophila pneumoniae or Legionella 
pneumophila. In contrast, older children and teenagers are more likely to acquire Mycoplasma  
pneumoniae and Chlamydophila pneumoniae than adults (Wubbel et al., 1999). 
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Rhino and corona viruses are the most predominant viral agent that caused ARIs, followed by 
parainfluenza viruses, respiratory syncytial virus (RSV), HMPV and HBoV.  
1.5 Antibacterial resistance  
Antibacterial resistance is an alarming issue now. Spreading of resistant organisms in developing 
countries is one of the major reasons that are increasing the problem of antibiotic resistance. 
Several factors such as unregulated dispensing and manufacture of antibacterial, shortened 
antibacterial therapy, inadequate access to effective drugs and sometimes drugs of questionable 
quality and overall poverty are likely to be contributing to antibacterial resistance (WHO, 2000). 
Antibiotic resistance is a natural occurrence. When an antibiotic is used, bacteria that can resist 
that antibiotic have chance of survival than those that are "susceptible." Susceptible bacteria are 
killed or inhibited by an antibiotic, resulting in a pressure for the survival of resistant strains of 
bacteria. Some bacteria are naturally resistant to certain types of antibiotics. However, bacteria 
may also become resistant in two ways:  
1) By a genetic mutation or 
 2) By acquiring resistance from another bacterium. 
1.5.1 Genetic mutation 
Mutations are the infrequent spontaneous changes of genetic sequence and are thought to occur 
in about one in one million to one in ten million cells. Diverse genetic mutations yield different 
types of resistance. Some mutations support the bacteria to produce potent chemicals (enzymes) 
that inactivate antibiotics, while other mutations eliminate or distort the cell target that the 
antibiotic attacks. Still others restricted their portals of entry mainly by cell’s porin proteins dose 
not allowing antibiotics into the cell, and others manufacture pumping mechanisms that export 
the antibiotic back outside which have entered into the cell cytoplasm so it never reaches its 
target. 
1.5.2 Transformation of genetic material  
Bacteria can acquire antibiotic resistance genes from other bacteria in several ways. By a process 
called "conjugation," bacteria can transfer its genetic material, including genes encoding 
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resistance to antibiotics (found on plasmids and transposons) from one bacterium to another. 
Viruses are another supportive mechanism for passing resistance traits between bacteria. The 
resistance traits from one bacterium are packaged into the head portion of the virus. The virus 
then injects the resistance traits into any new bacteria it attacks. Bacteria also have the capability 
to acquire naked, "free" DNA from their environment. 
Any bacteria that acquire resistance genes, whether by spontaneous mutation or genetic 
exchange with other bacteria, have the ability to resist one or more antibiotics. Because bacteria 
can collect multiple resistance traits over time, they can become resistant to many different 
groups of antibiotics. 
Genetically, antibiotic resistance spreads through bacteria populations both "vertically," when 
new generations inherit antibiotic resistance genes, and "horizontally," when bacteria share or 
exchange segments of genetic material with other bacteria. Horizontal gene transfer can even 
occur between different bacterial species. Naturally, antibiotic resistance spreads as bacteria 
themselves move from place to place; humans can pass the resistant bacteria to others by 
coughing, sneezing or contact with unwashed hands. 
The recent higher-levels of antibiotic-resistant bacteria are ascribed to the overuse and abuse of 
antibiotics. Patients sometimes take or suggested antibiotics unnecessarily, to treat viral illnesses 
like the common cold. 
1.6 Objectives of the study 
1) Identification of the respiratory isolates by microbiological culture method. 
2) Reconfirmation of multi-drug resistance of Klebsiella pneumonia and Enterobacter 
aggalomerans isolates by antibiogram. 
3) Plasmid curing of the MDR strains and checking its effect on the multi-drug resistance of 






CHAPTER 2: LITERATURE REVIEW 
 
2.1 Plasmid curing of bacteria 
Zaman et al. (2010) investigated the plasmid eliminating abilities of Ethidium bromide and 
sodium dodecyl sulfate on multi drug resistant Escherichia coli from urinary tract infection 
specimens. They used three different concentrations of each curing agent (Et-Br and SDS) and 
found that frequencies of cured cells were 14.29 % (with 100 μg/ml), 21.05 % (with 100 μg/ml), 
17.65 % (with 125 μg/ml) for Ethidium bromide and 7.4 % (with 10 % w/v) and 6.67 % (with 10 
% w/v) for sodium dodecyl sulfate. There were no cured cells from for 75 μg/ml Ethidium 
bromide and 8 and 12 % SDS. When profiles of wild type and plasmid cured strains were 
analyzed by electrophoresis they found that varying sizes plasmid bands yielded for wild type 
cells, but none was obtained for Et-Br cured cells.  
Another study which was conducted with Pseudomonas aeruginosa showed that no cured cells 
of Pseudomonas aeruginosa were obtained from 700 μg/ml Ethidium bromide treatment whereas 
in the treatment done for three incubation times using SDS at a concentration of 1% (W/V) with 
different incubation periods as curing agent, the bacterial colonies that lost their antibiotics 
resistance appeared with different curing rates. The results showed 75 - 100% of curing for 
streptomycin and gentamycin with little effect on erythromycin and trimethoprim (0 - 8%), while 
SDS had variable effect on other antibiotics resistance in some isolates. Curing of plasmid DNA 
by elevated temperature (45°C) revealed high percentage of curing for all antibiotics resistance. 
The percentages of bacterial colonies that lost their antibiotic resistance were 55- 100% for 
curing to all antibiotic resistance in the six tested isolates (Hayfaa et. al., 2013). 
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Another study showed that curing of Acinetobacter baumanii plasmids by 400 μg/ml Ethidium 
bromide was highly effective. Complete curing was achieved at 400 μg/ml of EtBr however 
lower concentration of 300 μg/ml also showed significant results (Pahwa et al., 2012). 
Curing of Klebsiella pneumoniae by using sodium dodecyl sulphate proved that the curing 
frequency about 6.25 × 10–4. which was very effective in curing the plasmid with a relatively 
high (Mansi et al., 2000). 
Plasmid curing experiment was done by Raja et al (2009), where they cured E. coli plasmid by 
using ethidium bromide, acridine orange, novobiocin, SDS and temperature at 40 °C .in their 
experiment they found that plasmid curing was achieved only by growing the strain treatment 
with 10 percent SDS while other curing agents and temperature at 40 °C were not effective.  
In another study, it was found that 1% of sodium dodecyl sulfate with different incubation, 
bacterial colonies that lost their antibiotics resistance appeared with different curing rates. The 
results showed 100% of curing for the antibiotic such as streptomycin resistance whiles for 
chloramphenicol and tetracycline the plasmid curing varied 17% to 83% and little effect of SDS 
on ampicillin and trimethoprime resistance in some isolates. In addition, curing of plasmid DNA 
by elevated temperature (45°C) revealed high percentage of curing for all antibiotics resistance 
.The percentages of bacterial colonies that lost their antibiotic resistance were more than 60% 








CHAPTER 3: METHODS AND MATERIALS 
3.1 Study place  
This study was conducted at the laboratory facility of Institute for developing Science and Health 
initiatives (IdeSHi).  
3.2 Period of Study  
This study was carried out between January 2015 and June 2015. 















                        
Figure 3.1: Flowchart of the study design. 
Specimen collection 
(Nasal Swab) 











3.4 Specimen processing 
3.4.1 Preparation 
Specimens stored at -70°C freezer were brought out and allowed to thaw. 
3.4.2 Culture 
3.4.2.1 Materials 
1. MacConkey agar medium 
2. P200 pipette  
3. Inoculating loop 
4. Bunsen burner  
3.4.2.2 Procedure 
By using a P200 pipette and sterile tip, MacConkey Agar media (For gram negative bacteria)  
was inoculated with a drop (10 μl- 1 loop) of the NS (Nasal Swab)-STGG and streaking  out 
using four quadrant streaking method and incubated for 18-24 hours at 35-37˚C in aerobic 
condition. 
 





3.5 Isolation and Identification 
3.5.1 Colony morphology   
3.5 1.1 Equipment and materials  
1. Microscope 
2. Inoculating loop 
3. Kim wipe 
3.5.1.2 Procedure 
A plate which has well-isolated colonies were used and the largest colonies were observed with 
the naked eye to determine general shape and pigmentation. a dissecting/stereoscopic microscope 
was used to get more details. The plate was then placed RIGHTSIDE UP on the stage, leaving 
the petri dish cover ON to protect from self-contamination. Two different magnifications were 
used to observe the plates—10X and 20X: To remove water condensation on the lid cover, a 
Kim Wipe was used. In order to determine consistency, an inoculating loop was used to pick up 
the colony. 
3.5.2 Gram staining 
3.5.2.1 Materials and reagent  
Glass slides, Bunsen burner, Crystal violet, Grams iodine solution, Acetone and Safranin. 
3.5.2.2 Procedure: 
Slide containing specimen fixed by heat by passing it over a heat source, such as a flame, with 
the help of forceps. The slide was passed very quickly through the flame to avoid excessive heat. 
Then the slide was placed on the staining tray. The fixed smear was flooded with crystal violet 
solution and allowed to remain for 1 minute. The crystal violet was rinsed off with distilled 
water. The slide was flooded with grams iodine solution mainly mordant and allowed to remain 
for one minute. The iodine solution was rinsed off with distilled water. The smear was 
decolorized with acetone for 30 second and immediately washed with distilled water. The smear 
was stained with safranin and allowed to wait for 30 seconds. After that safranin was rinsed off 
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with distilled or tap water. Slide was then dried on bibulous paper or absorbent paper and placed 
in an upright position. Results of the staining procedure were observed under the microscope 
using oil immersion. 
3.6 Biochemical Test 
Biochemical tests were performed according to the methods described and applied in 
Microbiology Laboratory of IdeSHi. The biochemical tests carried out were Triple sugar Iron 
Test, Citrate Utilization and Motility, Indole and Urea test. 
Table 3.1: Biochemical test result sheet is followed to identify respiratory disease causing 








Slant Butt H2S Gas Mot Ind Urea  Cit 
Klebsiella 
pneumoniae 





*K = alkaline, A= Acid, K/A=alkaline Acid. 
*TSI= triple sugar iron agar, MIU=motility Indole Urea, CA=Citrate agar. 
3.6.1 Equipment’s and materials 
1. Inoculating needle  
2. Rack or test tube holder 
3. Bunsen burner  
4. Fresh culture  
5. Incubator (37°C) 
i. 3.6.2 Procedure  
ii. 3.6.2.1 TSI (Triple Sugar Iron Agar):   
iii. The inoculating needle was sterilized in the blue flame of the Bunsen 
burner till it turned into red hot and then allowed to cool. Using aseptic 
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technique, single colony of the organism was taken from fresh culture in 
MacConkey with the platinum needle. A sterile TSI slant tube was taken 
from the rack, the cap was removed and the neck of the tube was again 
burnt into flame to maintain its sterility. The needle containing colony was 
stabbed into the medium up to the butt of the TSI tube, and then streak the 
needle back and forth along the surface of the slant. Again the neck of the 
TSI tube was burnt into the flame and capped it and placed it in the test 
tube rack. Then the caps of the TSI were loosened, incubated at 37oC for 
18 to 24 hours to observe carbohydrate fermentation, CO2 and H2S 
production. Glucose fermentation was shown by a yellow butt and red 
slant. Gas Produce if any, was seen trapped inside medium. Detection of 
H2S production was identified by black precipitation in the butt of the tube. 
Carbon di oxide gas production was indicated by splitting and cracking of 
the medium. 
3.6.2.2 Citrate utilization Test: 
Bacterial single colony was picked from the MacConkey agar plate culture 
by using a platinum needle and inoculated into the slope of Simmons’s 
citrate agar (Oxoid Ltd, England) and incubated overnight at 37˚C.If the 
organism had the ability to utilize citrate, the medium changed its color 
from green to Prussian blue; a negative slant would have no growth of 
bacteria and would remain green. 
3.6.2.3  MIU (Motility, Indole and Urea):  
Motile organism grows out from the stabbed line throughout the medium. 
Indole and urea positive reaction is indicated by the formation of pink 
color. 
3.6.2.4 Motility Test Agar  
     Motility test agar was used for the segregation of microorganisms on the 
basis of motility. Motility Agar was soft agar in a test tube without a 
slanted surface. Cells were stab-inoculated into the agar (the top surface 
was not inoculated). Non-motile bacteria would have grown only where 
they were inoculated. Motile bacteria would have grown along the stab 
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and would have swum out away from the stabbed area. Thus, a negative 
result was indicated by growth in a distinct zone directly along the stab. A 
positive result was indicated by diffuse (cloudy growth), especially at the 
top and bottom of the stab. By using an inoculating platinum needle a stab 
inoculation (about 2/3 of the way into the agar) was made from stock 
culture. Then the test tube was then incubated at appropriate temperature 
for 24 to 48 hours (up to 72 hours). After that culture was observed by 
holding it up to a light source.  
3.6.2.5 Indole Test  
Five gram of Para-dimethylaminobenzaldehyde was added to a sterile 
beaker. With a sterile glass pipette 25ml of methanol was taken to the 
beaker and mixed properly. After mixing 10ml of phosphoric acid was 
added drop by drop with a sterile glass pipette to the beaker and 
mixed carefully. A 0.45 µm filter was used to filter sterilization of the 
media and transfer it to sterile bottle. The prepared Indole reagent 
stored at 4°C.Sterile filter paper cut into 3 cm in length and 0.5 cm of 
wide by maintaining all the aseptic condition. The filter paper was 
taken into a sterile petri dish and 1ml of the indole reagent was added 
to the filter paper pieces. Then the filter papers were incubated 
overnight. One piece of overnight incubated filter paper was placed on 
the top of urease containing motility agar test tube. The indole reagent 
containing filter paper would change into pink color if the inoculated 
colony was a gram negative Enterobacteriaceae, in case of gram-
positive it would have remained unchanged. 
3.6.2.6 Oxidase Test 
The Oxidase test must be performed before performing Analytical 
profile Index of test microorganism. From a fresh bacterial culture a 
well isolated colony was picked by using a platinum loop and rubbed 
onto a small piece of filter paper containing drops of N NN' N' tetra 
methyl  p phenylenediamine dihydrochloride reagent. Inoculated area 
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of paper was kept for observing a color change within 10-30 seconds. 
Microorganisms are Oxidase positive when color changes to purple 
color (indophenols) within 10 seconds and microorganisms are 
Oxidase negative if color does not change. 
 
 
Figure 3.3: Oxidase reagent containing filter paper and N NN' N' tetramethyl p 
phenylenediamine dihydrochloride reagent (SIGMA). 
3.7 Analytical Profile Index (Enterobacteriaceae) for genus label identification 
The whole procedure was done in compliance with the protocol that has provided by the API 20 
E test kit by bioMérieux®. 
3.7.1 Aim 
To identify bacterial isolates using commercial biochemical test kits (bioMérieux API). 
3.7.2 Principle 
The API 20 E strip consists of 20 micro tubes containing dehydrated substrates. These tests are 
inoculated with a bacterial suspension that reconstitutes the media. During incubation, 
metabolism produces color changes that are either spontaneous or revealed by the addition of 
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reagents. The reactions are read according to the Reading Table and the identification is obtained 
by referring to the Analytical Profile Index or using the identification software. 
3.7.3 Procedure  
3.7.3.1 Preparation of the strip 
1. An incubation box (tray and lid) was prepared and about 5 ml of distilled water or 
demineralized distributed into the honeycombed wells of the tray to create a humid 
atmosphere. 
2. The strain reference was recorded on the elongated flap of the tray.  
3. The strip was removed from its packaging. 
4. Then the strip was placed in the incubation box. 
3.7.3.2 Preparation of the inoculums 
1. An ampoule of API NaCl 0.85 % Medium (5 ml) was opened.  
2. By using a pipette, a single well isolated colony was removed from an isolation plate of 
young cultures (18-24 hours old). 
3. It was then emulsification was done cautiously to achieve a homogeneous bacterial 
suspension. Suspension was used immediately after preparation.  
3.7.3.3 Inoculation of the strip 
1. Using the same pipette, both tube and cupule of the tests CIT, VP and GEL were filled 
with the bacterial suspension. 
2. Only the tube (and not the cupule) of the other tests was filled. 
3. An anaerobiosis condition was created in the tests ADH, LDC, ODC, H2S and URE by 
overlaying with mineral oil. 
4. Then the incubation box was closed and incubated at 36°C ± 2°C for 18-24 hours. 
3.7.4 Reading and Interpretation  
3.7.4.1 Reading the strip 




2.  When 3 or more tests (GLU test + or –) are positive, then all the spontaneous reactions 




      Identification was obtained with the numerical profile by the help of an expertise. 
Table 3.2: API Reading Table which were used to interpret API test results 
TEST Active 
ingredients  
Reactions  Negative Positive  
ONPG 2 -nitrophenyl 
ẞD 
galactopyranoside 
ẞ galactosidase  colorless Yellow 
ADH L- arginine Arginine dihydrolase yellow Red/orange 
 
LDC L- lysine Lysine decarboxylase yellow Red/orange 
 
ODC L- orthonithine Orthinine 
decarboxylase 
yellow Red/orange  




H2S production Colorless Black  
URE urea Urease yellow red 
 




IND L-tryptophane Indole production colorless  pink 
VP sodium pyruvate acetoin  colorless Pink 
GEL Gelatin gelatinase no diffusion black  
GLU D -glucose glucose  Blue Yellow 
MAN D -mannitol mannitol Blue yellow 
INO inositol inositol  Blue yellow 
SOR D -sorbitol sorbitol Blue yellow 
RHA L-rhamnose rhamnose  Blue yellow 
SAC D-sucrose sucrose  Blue yellow 
MEL D-melibiose melibiose Blue yellow 
AMY amygdalin amygdalin Blue yellow 
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3.8 Antibiotic Sensitivity Test 
Antibiotic susceptibility testing was performed in accordance with CLSI (Clinical Laboratories    
Standard Institutes) guidelines. 
Table 3.3: List of Antibiotics that were used to perform antibiotic sensitivity test 
Name of the Antibiotic  Disc potency OXOID ,England  
Sulphomethoxazole/ 
trimethoprim (SXT) 
25 μg CT0052B 
Cefotaxime ( CTX) 30 μg CT0166B 
Ampicillin (Amp) 10μg CT0003B 
Ceftazidime (CAZ) 30μg CT0412B 
Penicillin G(P  ) 10μg SP028-1CT 
Amoxycillin /Clavulanic acid 
(AMC) 
30μg CT0223B 
Tetracycline (TE) 30μg CT0054B 




Carbenicillin(CAR) 100μg CT0006B 
Nalidixic acid (NA) 30μg CT0031B 
Azithromycin(AZM) 15μg CT0906B 
Amikacin (AK) 30μg CT0107B 
Imipenem(IPM) 10μg CT0455B 
Ciprofloxacin (CIP) 5 μg CT0425 
Cefixime (CFM) 5 μg CT0653B 
Ceftriaxone(CRO) 30μg CT0417B 
Tobramycin (TOB) 10μg CT0056B 
Gentamicin (GEN) 10μg CT0024B 
Meropenem (MEM) 10μg CT0774B 
Levofloxacin (LEV) 5 μg CT1587B 






Figure 3.4: Antibiotic discs (oxoid, England) 
Table 3.4: Pathogen specific drug lists for determining Antibiotic Sensitivity Test (AST) that is 
followed in ideSHi Laboratory: 
Name of the species Antibiotic Sensitivity Test drug lists 




*In accordance to CLSI standards 
3.8.3 Enrichment of the culture  
Fresh bacterial single colony of the Enterobacter aggalomerans and Klebsiella pneumoniae were 
inoculated in cryovial tubes containing l ml of Mueller Hinton Broth (MHB) and kept for 
approximately 4 hours to be enriched. 
3.8.4 Procedure for Performing the Disk Diffusion Test 
Within 15 minutes after adjusting the turbidity of the inoculums suspension, a sterile cotton swab 
was dipped into the adjusted suspension. Swab was rotated several times and pressed firmly on 
the inside wall of the tube above the fluid level. This removed excess fluid from the swab. Then 
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the dried surface of an MHA plate was inoculated by streaking the swab over the entire sterile 
agar surface. This procedure was repeated by streaking two more times, the plate was rotating 
approximately 60° each time to ensure an even distribution of inoculums. As a final step, the rim 
of the agar was swabbed. Then the lid ajar was left for three to five minutes, but no more than 15 
minutes, to allow for any excess surface moisture to be absorbed before applying the drug-
impregnated disks. 
3.8.4.1 Placement of the antibiotic disks: Two sterile disks were placed on the surface of an 
agar plate, using a forceps. The forceps was sterilized by immersing the forceps in alcohol then 
igniting it. The disks were gently pressed with the forceps to ensure complete contact with the 
agar surface. The disks were placed away from the edge of the plates so that it is easily 
measured. Once all disks are in place, the plates were inverted, and placed them in a 37 °C 
incubator for 24 hour. 
 
Figure 3.5: Placement of antibiotic discs on MHA containing bacterial lawn culture. 
3.8.4.2 Measuring zone sizes 
Following incubation, the zone sizes were measured precisely using a ruler. All measurements 






Table 3.5 Zone Diameter Interpretive Standards* 
Name of the Antibiotic Resistant  mm* or 
less 




≤10 11-15 ≥16 
Cefotaxime ( CTX) ≤14 15-22 ≥23 
Ampicillin (Amp) ≤13 14--16 ≥17 
Ceftazidime (CAZ) <14 15-17 >18 
Penicillin G(P  ) - - - 
Amoxycillin (AMC) ≤13 14-17 ≥18 
Tetracycline (TE) ≤14 15-18 ≥19 
Netilmicin (NET) 12 13-14 15 
Piperacillin (TZP) ≤17 18-20 ≥21 
Carbenicillin(CAR) ≤19 20-22 ≥23 
Nalidixic acid (NA) ≤13 14-18 ≥19 
Azithromycin(AZM) - - - 
Amikacin (AK) ≤14 15-16 ≥17 
Imipenem (IPM) ≤13 14-15 ≥18 
Ciprofloxacin (CIP) ≤15 16-20 ≥21 
Cefixime (CFM) ≤15 15-18 ≥19 
Ceftriaxone( CRO) ≤13 14-20 >21 
Tobramycin (TOB) ≤12 13-14 ≥15 
Gentamicin (GEN) ≤12 13-14 ≥16 
Meropenem (MEM) ≤13 14-15 ≥16 
Levofloxacin (LEV) ≤13 14-16 ≥17 
Vancomycin (VA  ) - - - 
*In accordance to performance standards for Antimicrobial Disk Susceptibility Tests, CLSI 
(formerly NCCLS) 




3.9 Plasmid isolation (Birnboim, 1979) 
3.9.1 A test tube containing 3-5mls of LB (which contains the antibiotic selective for the 
bacterial culture) was inoculated with a single isolated colony picked from an LB agar plate 
which contains the selective antibiotic and grown the culture O/N at 37oC with shaking. 
3.9.2 1.5ml of the O/N culture was centrifuged in a microfuge tube for 1 min at 14,000 rpm. 
Then the supernatant was discarded. The bacterial pellet was re-suspended in 200 μl of Solution I 
(see appendix). 
3.9.3 200 μl of Solution II (see appendix IV) was added and mixed by inverting the tube gently. 
3.9.4 Again 200 μl of Solution III (see appendix IV) was added and mixed by inverting the tube 
gently. A white precipitate was formed. Tubes were centrifuged for 10min at 14,000rpm. Then 
the supernatant was transferred to a fresh tube.   Transfer any of the white pellets was avoided 
carefully. 
3.9.5 900ul of 100% ETOH (Ethyl alcohol) was added to the supernatant. It was mixed well by 
inverting the tube several times. Then the eppendorf tubes were centrifuged at 14,000rpm for 
20min. Removed and discarded supernatant. To the DNA pellet 100 μl of ice cold 75%ETOH 
was added. Again the tubes were centrifuged for 30sec. After that the supernatant were removed 
and discarded. All of the EtOH has been removed from the pellet. To remove supernatant 
completely the pellet was air dried 10-30 minutes. 
3.9.6 The pellet was re-suspended in 50ul of sterile ddH2O or TE buffer. Then the plasmid 
sample was stored at -20°C until it was run in electrophoresis gel. 
3.10 Gel electrophoresis 








Table 3.6 Equipment’s and materials that were needed for Gel electrophoresis 
Materials Instrument 
1. Agarose 1.Electrophoresis chamber 
2. TE Buffer 2. Casting tray 
3. Bromophenol blue 3. Combs 
4. DNA stain 4. power supply 
5. 1 kb DNA ladder standard  
 
3.10.2 Preparing the Agarose gel 
3.10.2.1 About 0.4g Agarose powder was measured and added it to a 100 ml flask. 50 ml TE 
Buffer was added to the flask.  Then the agarose was melted in a microwave until the solution 
becomes clear.  Then the solution was left to cool to about 50-55°C. 
3.10.2.2 The ends of the casting tray were sealed with two layers of tape. The combs were placed 
in the gel casting tray. 
3.10.2.3 The melted agarose solution poured into the casting tray and letting for cool until it was 
solid. When it appeared milky white then carefully the combs were pulled out and removed the 
tape.  
3.10.2.4 Then the gel was placed in the electrophoresis chamber. Enough TE Buffer was added 
so that there was about 2-3 mm of buffer over the gel. 
3.10.3 Loading the gel 
310.3.1 About 3 μl of bromophenol blue was loaded with 7 μl of DNA samples. Order of each 
sample were recorded that would be loaded on the gel.  
310.3.2 Samples with the DNA dye were tipped carefully into separate wells in the gel. Then the 




3.10.4 Running the gel 
3.10.4.1 The lid was placed on the gel box, connecting the electrodes. The electrode wires were 
connected to the power supply, making sure the positive (red) and negative (black) are correctly 
connected.  Then the power supply was turned to about 120 volts.  
3.10.4.2 To make sure that the current was running through the buffer, the system was checked 
by looking bubbles forming on each electrode. Then the power was let to run until the blue dye 
approaches the end of the gel. 
3.10.4.3 Then the power was turned off and the wires were disconnected from the power supply. 
The lid was removed of the electrophoresis chamber. Gel was separated from the tray by using 
gloves. 
3.10.4.4 Then the plasmid DNA bands were observed on Gel DocTM XR+ (BioRad,USA) 
machine. 
3.11 Plasmid curing 
Curing experiments were performed using sodium dodecyl sulfate (SDS), Ethidium bromide and 
elevated temperature (45°C) as curing agents. 
3.11.1 Plasmid curing by using Ethidium Bromide 
In this study modified Et-Br plasmid curing method was used. Modified procedure was found to 
be more convenient than the established methods .Several concentrations of Et-Br (0.1 mg/ml) 
were added to 5 ml of LB broth. Antibiotic resistant bacterial culture was inoculated to LB broth 
having Et-Br. Broth containing MDR strains were kept in a shaker incubator (37°C) for 
incubation (24 hrs.).After incubation, this culture was swabbed into the MHA Plates. Again 





Figure 3.6: Plasmid curing of E. aggalomerans and K. pneumoniae by using different 
concentration of Ethidium bromide. 
3.11.2 Curing of plasmid by sodium dodecyl sulfate (Reference: Tomoeda et al. (1974) 
The original Tomoeda plasmid curing method by SDS was slightly changed due to some 
unavailability of reagents. Test tube containing 5 ml of nutrient broth (MHB) was prepared by 
adding appropriate antibiotic (Ampicillin) at a final concentration (50 μg/ml), then inoculated 
with single colony of both isolates, and incubated at 37°C for 24. Then the culture was 
inoculated into the MH broth (MHB) containing 0.5, 1, 2 , 2.5,3,3.5 and 4% SDS (W/V) which 
were then incubated at 37°C for 24 h. Then Antibiogram was performed according to the CLSI 
guidelines and incubated at 37°C for 24 h, until the result appeared. 
 
Figure 3.7: Plasmid curing of E. aggalomerans and K. pneumoniae by using different 




3.11.3 Plasmid curing by physical agents (elevated temperature) (ref: Kheder, 2002) 
Single colony of both isolates was inoculated into 10 ml of Mueller Hinton broth (MHB). After 
incubation at 37°C for24 h, 0.2 ml of bacterial culture was inoculated into 10 ml of fresh nutrient 
broth and incubated at an elevated temperature of 45°C for 24 h with shaking at 100 rpm. 
Dilutions were performed up to 10-3 dilutions, then 0.1 ml of the  each three dilutions were 
spread on plates of MacConkey to observe whether the microorganisms were survived or not 
after treated with intercalating agent Ethidium bromide. Then the survival colonies were 
enriched in MHB about 4 hrs. Then the enriched cultures were plated onto MH agar which 
contain different antibiotics and at 37°C for 24 h.  
 
 
Figure 3.8: Enriched culture of MDR K. pneumoniae and E. aggalomerans treated in 









CHAPTER 4: RESULTS 
4.1 Isolation of gram negative bacteria: 
The nasal swab samples were collected randomly from the pediatric ward of Dhaka Medical 
College Hospital (DMCH) and Shaheed Suhrawardy Medical College Hospital (SSMCH) and 






Figure 4.1: Bacterial isolates from nasal samples were collected from patients (age < 5) 





4.2 Characterization of bacterial isolates 
Table 4.1 Colony characteristics of the isolates on MacConkey agar medium 
Isolate ID Colony characteristics  
Size Form Color margin Elevation 
AREI–DN-005 Small Circular (mucoid 
encapsulated) 
pink Entire Raised 
AREI-SN-014 pinpoint Circular (mucoid 
encapsulated) 
pink Entire Convex 
AREI-SN-044 Small Circular (mucoid 
encapsulated) 
pink Entire Raised 
AREI-SN-046 Pinpoint Circular (mucoid 
encapsulated) 
pink Entire Convex 
 
AREI-DN-005 and AREI-SN-044 both isolates had formed small sized mucoid encapsulated 
pink colored colonies on the medium. Whereas AREI-SN-014 and AREI-SN-046 isolates had 
formed pinpoint like pink colonies on the medium. AREI DN 005 and AREI -SN -044 had 
convex while AREI-SN-014 and AREI-SN-046 isolates had raised colonies. 
 
Figure 4.2: Bacterial colonies on MacConkey agar media. Pink color indicated that the 




4.2.2 Morphological characterization 
The isolates’ morphological features were determined by Gram staining. All the isolates retained 
the pink color implying that they were Gram negative rods as shown in figure 
 
AREI –DN-005                 AREI-SN-014 
 
 
AREI-SN-044          AREI-SN-046 
 






4.3 Biochemical Test Results 
Table 4.2Results of Biochemical Test of the isolates collected from MacConkey agar medium 
Isolate  Id  Biochemical test  
TSI  MIU  Plausible organism 
 Slant butt H2S Gas  Motility Ind U Cit   
AREI –DN-005  A A - +  - - - +  K. pneumoniae 
AREI-SN-014  A A - +  + - - +  Enterobacteriaceae 
spp. 
AREI-SN-044  A A - +  - - - +  K. pneumoniae 
AREI-SN-046  A A - +  + - - +  Enterobacteriaceae 
spp. 
 
*A=acidic, (+) =positive reaction, (-) =negative reaction  
In Table 4.2, AREI –DN-005 and AREI-SN-044 both isolates had produced acid and gas in TSI 
but had not produced H2S gas on TSI. Both of these isolates had shown negative results in MIU 
but had shown positive results in Citrate utilization test.  
Biochemical test results of AREI –DN-005 and AREI-SN-044 isolates were suggested that the 
isolates were K .pneumoniae. 
AREI-SN-014 and AREI-SN-046 isolates had produced acid and gas in TSI and showed positive 
results in citrate utilization test. AREI-SN-014 and AREI-SN-046 had shown motility positive in 
MIU.  
After observing their biochemical test results, it was hard to make any presumption of these 
organisms because both of these isolates showed similar biochemical test results as K. 
pneumoniae isolates but AREI-SN-014 and AREI-SN-046 isolates were motility positive 
whereas K. pneumoniae isolates were motility negative. It was suggested that AREI-SN-014 and 






Figure 4.4: Biochemical test results of four isolates (AREI- DN- 005 on the left, AREI-SN-




4.4 Oxidase Test  
Table 4.3 Oxidase test results of the isolates are given below  
Isolate  ID   Name of the 
organism 
 Oxidase Test result 
AREI –DN-005  K. pneumoniae   Negative 
AREI-SN-014  Enterobacteriaceae 
spp. 
  Negative 
AREI-SN-044  K. pneumoniae   Negative 
AREI-SN-046  Enterobacteriaceae 
spp. 
  Negative 
 
Oxidase test results (table 4.3) suggested that all of four nasal swab sample isolates showed 
negative results in oxidase test. A negative result in oxidase test meant that the test organisms 
were gram negative microorganisms and belonged to the Enterobacteriaceae family. 
 
Figure 4.6: Inoculated area of filter paper containing oxidase reagent was kept for 10-30 
seconds to observe a color change. After 20 seconds later no significant color changes had 
noticed and the test microorganisms were considered as oxidase negative. 
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4.5 Analytical Profile Index (Enterobacteriaceae) for genus label identification 
Table 4.4 Analytical Profile Index test results of the isolates  




  AREI-SN-044  AREI-SN-046 
ONPG  (+)ve  (+)ve  (+)ve  (+)ve 
ADH  (-)ve  (-)ve  (-)ve  (-)ve 
LDC  (-)ve  (-)ve  (-)ve  (-)ve 
ODC  (-)ve  (-)ve  (-)ve  (-)ve 
CIT  (+)ve  (+)ve  (+)ve  (+)ve 
H2S  (-)ve  (-)ve  (-)ve  (-)ve 
URE  (+)ve  (-)ve  (+)ve  (-)ve 
TDA  (-)ve  (-)ve  (-)ve  (-)ve 
IND  (-)ve  (-)ve  (-)ve  (-)ve 
VP  (+)ve  (+)ve  (+)ve  (+)ve 
GEL  (-)ve  (-)ve  (-)ve  (-)ve 
GLU  (+)ve  (+)ve  (+)ve  (+)ve 
MAN  (+)ve  (+)ve  (+)ve  (+)ve 
SOR  (+)ve  (-)ve  (+)ve  (-)ve 
RHA  (+)ve  (+)ve  (+)ve  (+)ve 
SAC  (+)ve  (+)ve  (+)ve  (+)ve 
MEL  (+)ve  (+)ve  (+)ve  (+)ve 
AMY  (+)ve  (+)ve  (+)ve  (+)ve 
ARA  (+)ve  (+)ve  (+)ve  (+)ve 
INO (+)ve ( +)ve (+)ve ( +)ve 

















API test results (Table 4.4) suggested that AREI –DN-005 and AREI-SN-044 isolates were 






Figure 4.7:  Identification of Klebsiella pneumoniae (AREI-SN-044) isolate by using API-
20E test kit.  
 
 
Figure 4.8: Identification of Enterobacter aggalomerans (AREI-SN-046) isolate by using 







4.6 Antibiotic sensitivity test (AST) 
After performing antibiogram/AST, two multidrug resistant (MDR) isolates were found among 
these four gram negative isolates. Table 4.5 Antibiotic sensitivity test results of four isolates. 















pattern Disc Zone 
(mm) 
pattern Disc Zone 
(mm) 
pattern Disc Zone 
(mm) 
pattern 
AMP 23 R CFM S 23 AK 0 R AK 21 S 
AZM 6 R CIP S 24 AZM 12 R AZM 8 R 
CFM 6 R COT S 27 CFM 0 R AMO 24 S 
CIP 19 R CRO S 26 CIP 0 R CFM 21 S 
COT 10 R APM S 30 CRO 0 R CTX 22 S 
FOX 6 R AZM R 9 GM10 0 R CHL 23 S 
IPM 17 S ERY S 32 IPM 0 R COT 28 S 
MEM 30 S GM10 S 22 LEV 14 S CIP 23 S 
NET 19 R IPM S 17 MEM 0 R CRO 27 S 
TOB 12 R LEV S 16 NET 0 R ERY 26 S 
TZP 10 R MEM S 18 PB 11 S GM10 17 S 
CAP 6 R PB R 12 RF 0 R LEV 24 S 
PB 10 R TOB S 19 TOB 0 R MEM 17 S 
      TZP 0 R TOB 18 S 
         AML 10 R 
*S= sensitive, R= resistant. 
Antibiotic test results had shown that (table 4.6) AREI-SN-044 isolate was resistant against 11 
antibiotics and showed sensitivity to two antibiotics including Imipenem and Meropenem. 
AREI-DN-005 isolate showed resistance against two antibiotics but showed sensitivity to 11 
antibiotics. AREI-SN-046 isolate was resistant to 12 antibiotics and sensitive to only two 

















Table 4.6 According to the antibiotic sensitivity test results two drug resistant isolates was 
found. 
Isolate  ID Name of the 
organism 
 Sensitivity pattern  
AREI-SN-044 Klebsiella 
pneumoniae 





 Sensitive  
AREI-SN-046 Enterobacter 
aggalomerans 
 Multidrug resistant  
AREI-SN-014 Enterobacter 
aggalomerans 
 Sensitive  
 
In the table above, an isolate resists more than 14 antibiotics called  multidrug resistant whereas 
if it resists less than14 antibiotics is called partially multidrug resistant. 
 
Figure 4.11: Partially multidrug resistant Klebsiella pneumoniae (AREI-SN-044) on left and 
multidrug Enterobacter aggalomerans (AREI-SN-046) on right side. 
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Table 4.7 To understand drug resistance pattern of these two isolates, a lists of antibiotic was 
prepared where antibiotics were classified into five classes according to their functional group.  
 
Drug specificity 
 Class of 
antibiotics 
Name of the drugs 









1.Beta lactam ring 
containing group 





















3.carboxylic acid moiety Fluroquinolone  Ciprofloxacin, 
Norfloxacin, 
Levofloxacin 
4. fluorine substituent Quinolones Ciprofloxacin , 
Norfloxacin 
 
5. macrolide ring 
containing group 
/macrocyclic lactone ring 















4.7 Molecular characterization 
The quality of plasmid DNA extracted from the two multidrug resistant bacterial isolates was 
analyzed on a 1% agarose gel stained with gel red. Figure 4.12 showed that gel photographs of 
plasmid DNA from the two MDR bacteria isolates. 
 
 
Figure 4.12: Agarose gel analysis of plasmid DNA from MDR K. Pneumoniae and MDR E. 
aggalomerans. First lane is the molecular ladder (1Kb ladder). Image had shown three 
plasmid DNA bands in both lanes which were approximately 20000 bp (0.02Mbp), 15000 





4.8 Plasmid Curing  
4.8.1 Plasmid curing by Ethidium bromide 




K. pneumoniae  E. 
aggalomerans 
 
IPM  LEV IPM  LEV 
(µg/ml) Clear Zone 
(mm) 




 Clear Zone (mm) 
40 24  19 24  19 
60 23  19 25  19 
80 25  16 23  19 
100 25  18 23  19 
120 23  17 22  16 
140 22  16 24  16 
160 23  17 23  16 
 
Both isolates had shown significant changes against Imipenem after cured by Et-Br. Before 
curing, both MDR isolates were resistant (of K. pneumoniae had 17 mm zone of inhibition where 
E. aggalomerans had 0 mm zone of inhibition) but after treated but using Et-Br both isolates 
became sensitive to imipenem. Both isolates had shown minor changes for levofloxacin (before 
curing, E.  aggalomerans had 14 mm zone of inhibition but after treated with Et-Br it increased 
about 19 mm). 
 
Figure 4.13: Antibiotic sensitivity test result of E. aggalomerans after treating with 120, 140 
and 160 μg/ml Ethidium bromides. 
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 Zone diameter 
(mm) 
40 10-1  IPM 26  IPM  25 
LEV 19  LEV  19 
10-3  IPM 26  IPM  24 
LEV 19  TOB  R 
60 10-1  CRO R  TOB  10 
TOB 8  CAZ  9 
10-3  CN R  P  R 
TZP 16  AK  17 
80 10-1  IPM 24  AZM  12 
P R  CTX  R 
10-3  MEM R  TZP  15 
C R  AZM  11 
100 10-1  AZM 11  CAR  R 
CFM R  CTX  R 
10-3  AZM 11  NET  R 
NET 14  AML  R 
120 10-1  TOB R  AZM  12 
AML R  NET  14 
10-3  C R  TZP  R 
CAR R  CAR  Cont. 
140 10-1  TZP 11  MEM  24 
TOB R  P  R 
10-3  IPM 24  NA  13 
AML R  TOB  7 
160 10-1  AZM 10  AK  14 
AK 15  AZM  40 
10-3  MEM 27  CN  R 
CRO R  CAZ  R 
*Cont. = contaminated 
Table 4.9 had shown AST results of two MDR isolates after performing serial dilution of Et-Br 
treated cultures. In this study, dilution of Et-Br treated cultures were performed up to 10-3 and 
first and third dilution were used to perform AST. It was done only for first and third dilution 




4.8.2 Plasmid curing by Sodium Dodecyl sulphate (SDS) 
Table 4.10 Antibiotic sensitivity test results (no serial dilution was performed for SDS cured 
cultures). 
SDS conc.  K. 
pneumoniae 
  E. aggalomerans 
0.5 % GEN CIP IPM  GEN AZM  
12 mm 12 mm 25 mm  14mm 12mm  
1% CIP GEN IPM  GEN AZM  
11mm 11mm 25 mm  11mm 10mm  
2% TOB CIP IPM  TOB CIP AZM 
R R 25 mm  R R 11mm 
2.5% CIP TOB IPM  TOB CIP AZM 
R R 27 mm  R R 11mm 
3% CN  IPM     
R  25 mm     
3.5% LEV  IPM  CN   
16 mm  25 mm  R   
4% LEV  IPM  AZM   




In table 4.10, K. pneumoniae had not shown substantial changes after treated with different 
concentration of SDS. After 0.5%, 1%, 2% of SDS treatment isolates had shown 12 mm 
inhibition against gentamycin and ciprofloxacin, resistant against tobramycin. According to the 
CLSI zone interpretation guidelines it should be ≥16 mm and ≥21 mm zone of inhibition for 
tobramycin gentamycin, ciprofloxacin respectively. But isolate had shown minimal effect against 
levofloxacin after treated with 3.5% and 4% SDS. 
E. aggalomerans isolate had shown about 25 mm inhibition against imipenem which is ≥18 mm 
that considered as sensitive according to the sensitivity patterns of CLSI guidelines. Isolate had 
shown intermediate effect against gentamycin after treated by 0.5% of SDS.  From the treatment 
with 0.5, 1.2.2.5, 3, 3.5 and 4% SDS, Klebsiella pneumoniae had not shown significant effect 





4.8.3 Plasmid curing by physical agent (temperature) 
Table 4.11 Results of antibiotic sensitivity test before performing serial dilution. 
Name of the 
organism 
K. pneumoniae  E. aggalomerans 
 Disc Zone (mm)  Disc Zone (mm) 
AZM 9  IPM 24 
Antibiogram 
test results 
AMP R  AK 15 
CFM R  AZM 10 
NET R  TOB 8 
TOB R  TZP 14 
TZP R  NET 12 
   CRO R 
 
Table 4.11 had shown that E. aggalomerans had significant changes after treated with elevated 
temperature. E. aggalomerans were resistant to antibiotic IPM, AK, AZM, TOB, TZP and NET 
but after treated with elevated temperature it had not shown inhibition against those antibiotics. 





Figure 4.14: AST results of elevated temperature cured Enterobacter aggalomerans (AREI-










10-1 Disc  Zone(mm) Disc  Zone(mm) 
AK  15 AK  R 
 CRO  R CRO  R 
TOB  9 TOB  R 
10-2 AZM  10 AZM  10 
CAR  R CAR  R 
 LEV  17 IPM  R 
10-3 NET  13 NET  R 
CFM  R CFM  R 
 TZP  14 TZP  R 
 
Table 4.12 had shown different results of AST after performing serial dilutions of temperature 
cured E. aggalomerans cultures. Before performing serial dilution, temperature cured E. 
aggalomerans had shown inhibition against IPM =24 mm, AK=15mm, AZM=10mm, 
TOB=8mm, TZP=14mm, NET=12mm (table 4.11) but after serial dilution (Table 4.12) it had 
shown inhibition against those antibiotics.  
K. pneumoniae had shown inhibition against AK=15 mm, Tob=9mm, Azm=10 mm, Lev=17 
mm, Net= 13 mm and Tzp=14 mm. While in table 4.11, K. pneumoniae isolate was completely 
resistant to all of these selected antibiotics except Azithromycin. 
According to the antibiogram result, MDR Klebsiella pneumoniae had shown comparatively 









CHAPTER 5: DICUSSION 
 
ARIs are the major cause of mortality among children aged less than 5 years, especially in 
developing countries. Worldwide, 20% mortality among children aged less than 5 years is 
attributed to respiratory tract infections (mostly pneumonia associated). Although the spread of 
ARI is worldwide, its impact is different in developed countries as opposed to developing ones. 
Whereas 1% to 3% of the deaths in children fewer than five years of age in developed countries 
are due to pneumonia, the disease causes 10% to 25% of these deaths in the developing 
countries. Infants have the highest risk of pneumonia in their first three months of life. Nearly 
70-75% of all deaths in infants are due to pneumonia. In Bangladesh, it is estimated that one in 
five deaths of children under-five is due to pneumonia (UNICEF, 1986). 
In the present study, total 196 nasal samples were collected from two renowned Medical college 
hospitals in Dhaka city and tested in Institute for developing science and health initiatives 
(IdeSHi) laboratory. Very few (about 4%) Gram-negative bacteria were isolated from 196 nasal 
swabs specimens of <5 children. 
 To isolate gram negative bacteria, nasal samples were inoculated onto MacConkey agar. The 
complete chart of colony characteristics of the isolates was given in table 4.1.The morphological 
characteristics of the isolates were determined by Gram staining. All the isolates retained the 
pink color of crystal violet stain indicating that they were Gram negative rods. Biochemical tests 
were performed separately for each of isolates. Biochemical tests confirmed two isolates as K. 
pneumoniae but two other isolates were needed to confirm in further confirmation test (table 
4.2).  
To identify the unknown isolates, analytical profile index test kits were used. Before performing 
API test, oxidase tests were performed. Oxidase test results confirmed that these four isolates 
were gram negative bacteria (table 4.3). The complete report of API test results was given in 
above tables. According to the API confirmation test results, two of four isolates were E. 
aggalomerans and remaining two were K. pneumoniae. Antibiotic sensitivity test results showed 
one isolate was resistant to more than 12 antibiotics and another one was resistant to 11 
antibiotics. Two multi drug resistant isolates were obtained which were resistant to multiple 
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clinically used antibiotics, including extended-spectrum β-lactams, fluoroquinolone, 
aminoglycosides, trimethoprim, and sulfamethoxazoles.  In the present study two sensitive 
isolates and two multidrug resistant (MDR) isolates were detected among these four gram 
negative isolates (table 4.7). 
Molecular characterization of two MDR isolates were done after plasmid isolation which showed 
that both drug resistant isolates contained three plasmid DNA bands in both lanes , which were 
approximately 20000 bp (0.02Mbp), 15000 bp (0.015 Mbp) and 700 bp (0.0007 Mbp)  base pair 
sized (figure: 4.7.1). Basically, Klebsiella pneumoniae have five plasmids, pKPN3, pKPN4, 
pKPN5, pKPN6, and pKPN7. Each of plasmid length is 0.18 Mbp, 0.11 Mbp, 0.089 Mbp, 
0.0043 Mbp, and 0.0035 Mbp 
(Source:https://microbewiki.kenyon.edu/index.php/Klebsiella_pneumoniae). Klebsiella 
pneumoniae includes numerous mechanisms for antibiotic resistance, many of which are located 
on plasmid DNA (Hudson et al., 2014). Pinglei et al. (2011) reported K. pneumoniae genome 
sequence of HS11286 strain. It contains one chromosome (5.3 Mbp), three multidrug resistance 
plasmids (∼110 kbp), including a carbapenemase producer, and three small plasmids (∼3 kbp). 
Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria are highly drug-resistant to 
Carbapenem grouped drug. That is the main reason that Carbapenem antibiotics are not effective 
against KPC-producing K. pneumoniae (Arnold et al, 2011). In the present study, we used 1kb 
molecular ladder which was for linear DNA. Usually plasmid DNA’s are circular in sizes and 
ladder which was mainly used for linear DNA might have resultant dissimilarity between the 
original plasmid sizes and the plasmid sizes which we had found in our study after 
electrophoretic separation. Another possibility could be like that there might have more than five 
types of plasmid in K. pneumoniae. The more scientific investigation is required to prove this 
assumption. As very limited research were done on ARI causing Enterobacter aggalomerans 
that is why we were unable to define its plasmid sizes.  
In the present study, it was found that K. pneumoniae isolate was resistant to a combination drug 
of sulfonamide besides those five different groups of antibiotics. These two isolates K. 
pneumoniae and E. aggalomerans were resistant against the drugs containing Beta- lactam ring, 
amino glycoside, fluoroquinolone, quinolones and macrolide. These two extended-spectrum 
beta-lactamases (ESBL)-producing organisms were resistant against 10 beta lactam ring 
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containing drugs. There is a process called curing to observe whether the plasmids of bacterium 
contain the resistant gene of interest or not (Caro et al., 1984). Curing may occur naturally 
through cell division or by treating the cells with chemical and physical agents (Snyder et al, 
1997).  
In present study, several chemical treatment were used to cure plasmid of the isolates by using 
sodium dodecyl sulfate (SDS) and fluorescent dye Ethidium bromide for removing the plasmids 
from the bacteria. Physical treatment such as elevated temperature was also applied to eradicate 
plasmid from the organisms. 
 After treating in elevated temperature results (Table 4.11) showed that E. aggalomerans isolate 
was missing its plasmids containing resistance genes against imipenem but maintained resistance 
against all other antibiotics. Studies have been made on the effect of elevated temperature on 
DNA synthesis and plasmid curing. Among them, May et al. (1964) obtained a high frequency of 
loss after growing some bacterial strains at elevated temperature. Ahmad (1989) and Bennett 
(2008) reported that there is a clear effect of elevated temperature on curing the plasmid DNA 
content of isolates of P. aeruginosa which is in agreement with the results of this study. 
In the meantime, K .pneumoniae isolate had maintained its resistance to Cefixime, azithromycin, 
piperacillin and tobramycin after being treated by elevated temperature. It may be occurred due 
to the location of its resistant genes on chromosomal DNA instead of plasmid DNA. A similar 
result was reported when Michael et al. worked with P. aeruginosa isolates. In their study, they 
had found that after treating with elevated temperature, isolates had not shown any changes. 
Later further investigation has showed that the resistant genes of P. aeruginosa were located on 
chromosomal DNA instead of plasmid DNA. 
Plasmid curing by using Ethidium bromide in different concentration showed meaningful results 
for E. aggalomerans. It has become sensitive to beta lactam ring containing drugs however K. 
pneumoniae remained resistant. The result showed that the Ethidium bromide had no effect on 
curing of plasmid DNA carrying the levofloxacin, chloramphenicol, tobramycin, gentamycin. 
Piperacillin, penicillin, Meropenem, Carbenicillin, azithromycin, Cefixime and Netilmicin 
resistance genes, for both isolates. Rabab et al (2010) also found similar results while working 
with Et-Br for curing plasmid of P. aeruginosa. 
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Plasmid curing by different concentration of SDS also showed opposing results for E. 
aggalomerans and K. pneumoniae.  
K. pneumoniae had not shown considerable changes after treated with different concentration of 
SDS. 0.5% SDS and its higher concentration had a significant effect on E. aggalomerans. SDS 
treated E. aggalomerans had showed sensitivity to imipenem but had less effect against 
gentamycin, tobramycin, ciprofloxacin and azithromycin. The cured plasmid of E. aggalomerans 
may be the R-plasmid which harbors most of antibiotics resistance genes. Adachi et al. (1972) 
had found that SDS was only effective in elimination of sex (F) and R plasmids in E. coli in a 
high frequency at concentration higher than 1%, and reported that the longer incubation times 
(24 to 72 hrs.), higher the frequency of sensitive. 
Another possibility of less effect of SDS treatment is the copy number of plasmids or the amount 
of antibiotic- inactivating enzymes that may interfere. A study made on the effect of SDS 
treatment had (Sonstein and Baldwin, 1972) elucidated that the effectiveness of SDS may be 












CONCLUSION AND FUTURE PERSPECTIVE 
The presence of multidrug-resistant microorganisms associated with ARI’s in children aged< 5 
can cause a severe effect on infant health and increase the mortality and morbidity rate. High 
dosage or overuse of antibiotics has deteriorated the effectiveness of clinically used antibiotics. 
Nowadays for a simple complication during pregnancy women are suggested medication 
containing high dosage antibiotics which are affecting the health of developing fetus. In the 
present study, most of the nasal samples were collected from the patient aged 2 day to 6 months 
and most of them were suffering from typical pneumonia after their birth. Nevertheless, the 
presence of multidrug resistant bacteria implicated that medication which was provided to their 
mother to cure infection badly affects their immunity.  The Immune system of these <5 children 
could not able to resist common bacterial infection which turned into multidrug resistance. The 
poor health condition of these <5 children also may contribute to causing ARIs among these 
ARIs patients admitted in hospitals. Unusual antibiotic usage should be firmly prohibited to 
avoid child health deterioration.  
Strict and proper medication during pregnancy and after birth is needed to save the infant from 
the acute respiratory infection caused by multidrug- resistant bacteria. 
This study has several imperfections. There was an unavailability of many materials that was 
needed while working with MDR strains. So results which were obtained may have dissimilarity 
with the results of other studies. Further research is needed to be carried out for better results. As 
we have found two multidrug resistant gram negative bacterial isolates, in future we will be 
proceed for next generation sequencing where appropriate primer sequence will be used to 
characterize the resistant genes which are contributing to becoming multidrug-resistant. A more 
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APP.I.I: Oxidase Test principle  
During aerobic respiration in electron transport chain, cytochrome oxidase 
(The enzyme cytochrome c oxidase/ Complex IV (EC 1.9.3.1), is a bulky transmembrane 
protein complex found in bacteria and the mitochondrion of eukaryotes)  catalyzes the oxidation 
of reduced cytochrome (Cytochromes are hemeproteins containing heme groups and are 
primarily responsible for the generation of ATP via electron transport.) by molecular oxygen that 
results the formation of H2O and H2O2. The oxidase test is used to identify bacteria that produce 
cytochrome c oxidase. When present, the cytochrome c oxidase oxidizes the reagent 
(tetramethyl-p-phenylenediamine) to (indophenols) purple color end product. When the enzyme 
is not present, the reagent remains reduced and is colorless. 
Aerobic bacteria, some facultative anaerobes and microaerophiles exhibit Oxidase activity. 
Genera Neisseria and Pseduomonas are Oxidase positive and Enterobacteriaceae are Oxidase 
negative. 
 
Figure (APP. I.I): Basic principle of oxidase test in diagram. 
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APP.I.II: Citrate Test  
Some microorganisms are capable of using citrate as a carbon source in the absence of 
fermentable glucose or lactose for their energy. The ability depends on the presence of a citrate 
permease that facilitates the transport of the citrate in the cell. Citrate is the first major 
intermediate in the Krebs cycle and is produced by the condensation of active acetyl with 
oxalacetic acid. Citrate is acted on by the enzyme citrase which produces oxalacetic acid and 
acetate. These products are the enzymatically converted to pyruvic acid and carbon di oxide.  
During this reaction the medium becomes alkaline – the carbon di oxide that is generated 
combines with sodium and water to form sodium carbonate, an alkaline product. 
The presence of sodium carbonate changes the bromthymol blue indicator incorporated into the 
medium from green to Prussian blue. (Cappuccino, microbiology lab manual) 
 
Figure (APP I.II): Schematic presentation of citrate test  
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APP.I.III:  Indole Test 
Indole test is used to determine the ability of an organism to spilt amino acid tryptophan to form 
the compound Indole. Tryptophan is hydrolyzed by tryptophanase to produce three possible end 
products – one of which is Indole. Indole production is detected from Para-
dimethylaminobenzaldehyde reagent which mixture component is phosphoric acid and methanol; 
this reacts with indole to produce a colored compound. Indole test is a commonly used 
biochemical test. Indole test helps to differentiate Enterobacteriaceae and other genera. 
 
Figure (APP I.III):  Reaction of Indole Test 
APP.I.IV: Urease test  
Urea is waste product excreted in urine by animals. Some enteric bacteria produce the 




Figure (APP I.IV): Urease reaction  
Urease, which is produced by some microorganisms, is an enzyme that is especially 
helpful in the identification of Proteus vulgaris, although other organisms may produce 
urease, their action on the substrate urea tends to be slower than that seen with Proteus 
species. Therefore this test serves to rapidly distinguish members of this genus from other 
lactose non fermenting enteric microorganisms. 
  
Urease is a hydrolytic enzyme that attacks the nitrogen and carbon bond in amide 
compounds such as urea and forms the alkaline end product ammonia. The presence of 
urease is detectable when the organisms are grown in a urea broth medium containing the 
pH indicator phenol red. As the substrate urea is split into its products, the presence of 
ammonia creates an alkaline environment that causes the phenol red to turn to deep pink. 
This is a positive reaction for the presence of urease. Failure of deep pink color to 











(APP.II.I): Media composition 
Name of the medium Composition Direction 
 
Triple Sugar Iron  
DifcoTM Triple sugar 
Iron agar (Becton, 
Dickson and 
company) 
Base for the 
differentiation of 
gram negative enteric 
bacilli. 
 
Approximate formula*per liter. 
1. Beef extract =3.0 g  
2. Yeast extracts =3.0 g 
3. Pancreatic digest of 
casein =15.0 g 
4. Proteose peptone no.3 
= 5 g 
5. Dextrose= 1 g 
6. Lactose =10 g 
7. Sucrose=10g  
8. Ferrous sulfate =0 .2 g 
9. Sodium chloride = 5g 
10. Sodium thiosulfate 
=0.3 g 
11. Agar= 12 g 
12. Phenol red=0.024g 
*adjusted and/or supplemented 
as required to meet 
performance criteria. 
For laboratory use. Final pH 
7.4 
 
65 g of the powder was suspended in 
1L of purified water. Then it mixed 
thoroughly. Heated with frequent 
agitation and boiled for 1 minute to 
completely dissolve the powder. Then 
it was dispensed into tubes and 
autoclaved at 121˚C for 15 minutes. 
Then the hot solution was cooled in a 
slanted position so that deep butts are 
formed. Test samples of the finished 
product for performance using stable, 







Approx. composition per 
liter: 





3. Sodium ammonium 
phosphate=0.8g 
4. Sodium citrate, 
tribasic=2.0g  
5. Sodium chloride=5.0g 
6. Bromothymol 
blue=0.08g  
7. Agar= 15.0g  
pH 7.0 ± 0.2 at 25°C 
23 g of OXOID was suspended in 1 
liter of distilled water and boiled until 
it dissolved completely. Then 
Sterilized by autoclaving at 121°C for 
15 minutes.  5ml of the autoclaved 
media was added in test tubes and 







Preparation of gel 
1. NaCl= 0.5g 
2. Agar= 0.4g 
3. KH2PO2=0.2g 
4. Peptone=3.0g 
Preparation of 10ml phenol 
red (0.25%) 
       0.025g of phenol red was 
added in 10ml of dH2O 
Preparation of urea solution 
(20%) 
2g of urea was added and 




90ml of gel was prepared by adding 
dH2O. 
200µl of phenol red (0.25%) was 
added to the gel. 
Then the mixer was autoclaved. 
After autoclaving the solution was 
kept to cool down just before it 
solidify. 
Urea solution was sterilized by using 
filter sterilization.  
10ml of prepared urea solution was 
added to the autoclaved 90ml mixture 
and was mixed them well. 
 
DifcoTM  MacConkey 
Agar 
Base for the isolation 
and differentiation of 
enteric organisms.  
 
Approximate formula* per liter 
1. Pancreatic digest of 
gelatin =17 g 
2. Peptones (meat and 
casein) =3 g 
3. Lactose = 10 g 
4. Bile salts no.3 =1.5g  
5. Sodium chloride = 5 g 
6. Agar =13.5 g 
7. Neutral red =0.03 g 
8. Crystal violet = 0.001 
gm 
 Final pH = 7.1 ±0.2 
 
50 g of the powder was suspended in 1 
l of purified water. Then it mixed 
thoroughly. Heated with frequent 
agitation and boiled for 1minute to 
completely dissolve the powder. Then 
the solution was autoclaved at 121°C 
for 15 minutes. Avoid overheating. 
Test samples of the finished product 





CM0405) and Agar  
 
500 g makes 23.8 liters  
1. Typical formula *( g/l) 
2. Beef, dehydrated 
infusion from =300 g 
3. Casein hydrolysate= 
17.5 g  
4. Starch = 1.5 g      
5. Divalent cation content 
of this lot 2.195 mg 
Ca++ per liter, 4.358 mg 
Mg++ per liter. For 100 
ml broth agar is needed 
1.5 gm.  
 
For 100 ml MHB 2.1 gm of MH 
powder was added to dH2O water. For 
Mueller Hinton Agar 1.5g/100ml was 




BactoTM  Todd 
Hewitt Broth  






Approximate formula *per liter 
1. Heart infusion from 
500g =3.1 g 
2. Neopeptone =20 g 
3. Dextrose =2 g 
4. Sodium chloride =2 g 
5. Disodium phosphate 
=0.4 g 
6. Sodium carbonate-2.5 g 
Final pH 7.8 ±0.2  
 
30 g of the powder was Dissolved in 1 
liter if purified water. Autoclave at 
121°C for 15 minutes. Test samples of 
finished product for performance 







(for 100 ml broth ) 
 
1. Skim milk powder 
(OXOID LP0031) =2g  
2. Trypton soya broth 
(OXOID CMO129) = 3g 
3. Glucose =0.5 g/dextrose 
4. Glycerol =10 ml 
5. dH2O =100 ml  
 
First the solution was Autoclave, 
stirred and then pours into 1ml per 
cryovials.  
 
Luria Bertani Broth 
 
1. Trypton =10g/L 
2. Yeast extracts =5 g/L 
3. Sodium chloride 
=10g/L 
4. dH2O =950 ml 
5. Agar= 75 g/L (for LB 
agar)  
 
Preparation of LB broth for 1 Litter 
1. We measured 10 g of Trypton, 5 
g of Yeast Extract and 10 g of 
Sodium Chloride in a sterile 
conical flask. 
2. Then we added around 950 ml of 
distilled water and mixed well to 
dissolve all the ingredients and 
added distilled water to make 1 
liter of the solution followed by 
autoclave the solution at 121°C 
for 15 minutes to sterilize. 
3. The prepared broth solution was 













(APP. III.I): Gram staining Solution 
Name of the reagent Component Direction 
Crystal violet staining reagent 
 
Solution A for crystal violet 
staining reagent 
Crystal violet (certified 90% dye 
content), 2g  
Ethanol, 95% (vol/vol), 20 ml  
Solution B for crystal violet 
staining reagent 
Ammonium oxalate, 0.8 g 
Distilled water, 80 ml  
 
Solution A and B was 
mixed to obtain crystal 
violet staining 
reagent. Stored for 24 h 
and filtered through 
paper prior to use.  
 
Mordant: Gram's Iodine 
 
Iodine, 1.0 g  
Potassium iodide, 2.0 g  
distilled water, 300 ml 
 
 
Iodine and potassium 
iodide were grinded in a 
mortar and water slowly 
with continuous 
grinding until the iodine 
was dissolved. Then the 
solution was stored in 
amber bottles.  
Decolorizing Agent 
 
Ethanol, 95% (vol/vol) 
*Alternate Decolorizing Agent 
Acetone, 50 ml  
Ethanol (95%), 50 ml 
 
 




 2.5g Safranin O  
100 ml 95% Ethanol 
Working Solution: 
10 ml Stock Solution  








(APP.III.II): Reagents for Biochemical Test 






1. Para dimethylamino 
benzaldegyde. 
2. Phosphoric acid. 
3. methanol 
4. Filter paper. 
5. 0.45 µm filter. 
 
1. 5g of Para-
dimethylaminobenzaldehy
de was taken and added to 
a sterile beaker 
2. With a sterile glass pipette 
take 25ml of methanol and 
to the beaker and mix 
properly. 
3. After mixing 10ml of 
phosphoric acid was added 
drop by drop with a sterile 
glass pipette to the beaker 
and mixed carefully. 
4. A 0.45 µm filter was taken 
for filter sterilization of the 
media and transferred it to 
sterile bottle. 
5. The prepared Indole 
reagent was stored at 4°C. 
6. Sterile filter paper was cut 
into 3 cm in length and 0.5 
cm of wide by maintaining 
all the aseptic condition. 
7. Then the filter was taken 
into a sterile petri dish and 
1ml of the Indole reagent 
was added to the filter 
paper pieces. 
8. Then the filter papers were 
incubated overnight and 
used it when it is dry.  
 
 
Kovacs oxidase reagent  
 




0.6-0.7 gm. of N N N' N' 
tetramethyl p phenylene 
diamine dihydrochloride 













Solution I 50mM Tris pH 8.0 with HCl, 
10mM EDTA, 100ug/ml 
RNase A 
 
For 1 liter: 6.06g Tris base 
was dissolved, 3.72g EDTA 
2H20 in 800ml H20. Adjust the 
pH to 8.0 with HCl. 
Adjusted the volume to 1 liter 
with ddH20. 
 
Solution II 200mM NaOH, 1%SDS 
 
For 1 liter: 8.0g NaOH pellets 
were dissolved in 950ml of 
ddH2O, 50ml of 20% SDS 
solution. The final volume 
was came out to 1 Liter 
Solution III 3.0M Potassium Acetate, 
pH5.5 
For 1 liter: 294.5g potassium 
acetate was dissolved in 
500ml of H2O. Then the pH 
adjusted to 5.5 with glacial 
acetic acid (~110ml). Then the 
volume was adjusted to 1 liter 
with ddH2O. 
 
Tris EDTA buffer solution  TE 10mM Tris pH 8.0 with 
HCl, 1mM EDTA 
 
For 1 liter: 1.21g Tris base 
was dissolved and 0.37g 
EDTA 2H2O in 800ml of 














APP.V.I: Instruments  
The significant equipment’s that used during the study are listed below  
Name of the Instrument  Company 
Molecular imager ,GelDocTM XRT with image labTM  software  
 
Bio-Rad ,USA 
Micro oven   Miyako , japan 
PowerpacTM basic   Bio-Rad ,USA 
Jenway 3510 pH Meter  Keison,UK 
Centrifuge machine   Thermo Fisher Scientific,USA 
WisVen oven (60°C)  Witeg ,Germany  
Olympus CKX41 inverted microscope   MSAC LTD ,UK 
Kimwipes® EX-L Laboratory Wipes  Kimberly Clark 
Professional,USA 
Incubator   Memmert, Germany  
4°C Freezers ,Vest frost NFG 309  Vestfrost solution.com , 
Denmark 
Wiseclave Autoclave   Witeg ,Germany 
Lexicon® II Ultra-low Temperature Freezer (-80°C)  ESCOglobal,USA 





Weighing balance  Japan  
WiseMix VM Vortex Mixer, WVM00010  Interlab ,NZ 
Pipette 1000 μl  Gilson Inc,UK 
Pipette 20-200 μl  Costar  
 
 
